IL6 and cancer: Chronic IR is found in malignant tumors, but not in benign tumors, and is presumed to contribute to cancer cachexia due to chronic exposure to proinflammatory cytokines, tumor necrosis factor (TNF)-α, IL-6, and insulin growth factor-binding protein [23, 24].